Early Detection of Genetic Cardiomyopathies in Relatives | 155 46. Verdonschot JAJ, Merken JJ, Brunner-La Rocca H-P, et al. Value of Speckle Tracking–Based Deformation Analysis in Screening Relatives of Patients With Asymptomatic Dilated Cardiomyopathy. JACC Cardiovasc Imaging. 2020;13(2):549-558. 47. Taha K, te Rijdt WP, Verstraelen TE, et al. Early Mechanical Alterations in Phospholamban Mutation Carriers. JACC Cardiovasc Imaging. 2021;14(5):885-896. 48. Sefa Okten M, Tuluce K, Yakar Tuluce S, et al. Screening first-degree relatives of patients with idiopathic dilated cardiomyopathy. Herz. 2017;42(7):669-676. 49. van der Bijl P, Bootsma M, Hiemstra YL, Ajmone Marsan N, Bax JJ, Delgado V. Left ventricular 2D speckle tracking echocardiography for detection of systolic dysfunction in genetic, dilated cardiomyopathies. Eur Heart J Cardiovasc Imaging. 2019;20(6):694-699. 50. Paldino A, De Angelis G, Dal Ferro M, et al. High prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients. Int J Cardiol. 2021;324:108-114. 51. Lakdawala NK, Thune JJ, Colan SD, et al. Subtle Abnormalities in Contractile Function Are an Early Manifestation of Sarcomere Mutations in Dilated Cardiomyopathy. Circ Cardiovasc Genet. 2012;5(5):503-510. 52. Akhan O, Demir E, Dogdus M, Cakan FO, Nalbantgil S. Speckle tracking echocardiography and left ventricular twist mechanics: predictive capabilities for noncompaction cardiomyopathy in the first degree relatives. Int J Cardiovasc Imaging. 2021;37(2):429-438. 53. Bos JM, Towbin JA, Ackerman MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol. 2009;54(3):201-211. 54. Robinson P, Griffiths PJ, Watkins H, Redwood CS. Dilated and Hypertrophic Cardiomyopathy Mutations in Troponin and α-Tropomyosin Have Opposing Effects on the Calcium Affinity of Cardiac Thin Filaments. Circ Res. 2007;101(12):1266-1273. 55. Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Cardiol. 1995;26(7):1699-1708. 56. Te Riele ASJM, James CA, Philips B, et al. Mutation-positive arrhythmogenic right ventricular dysplasia/ cardiomyopathy: the triangle of dysplasia displaced. J Cardiovasc Electrophysiol. 2013;24(12):1311-1320. 57. Kirkels FP, Lie ØH, Cramer MJ, et al. Right Ventricular Functional Abnormalities in Arrhythmogenic Cardiomyopathy. JACC Cardiovasc Imaging. 2021;14(5):900-910. 58. Spirito P, Bellone P, Harris KM, Bernabò P, Bruzzi P, Maron BJ. Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy. N Engl J Med. 2000;342(24):1778-1785. 59. Argirò A, Zampieri M, Berteotti M, et al. Emerging Medical Treatment for Hypertrophic Cardiomyopathy. J Clin Med. 2021;10(5):951. 60. Ho CY, Day SM, Axelsson A, et al. Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial. Nat Med. 2021:27(10):1818-24. 61. Tabassian M, Sunderji I, Erdei T, et al. Diagnosis of Heart Failure With Preserved Ejection Fraction: Machine Learning of Spatiotemporal Variations in Left Ventricular Deformation. J Am Soc Echocardiogr. 2018;31(12):1272-84. 62. van de Leur R, Taha K, Bos MN, et al. Discovering and Visualizing Disease-specific Electrocardiogram Features Using Deep Learning: Proof-of-concept in Phospholamban Gene Mutation Carriers. Circ Arrhythm Electrophysiol. 2021: 14(2):e009056. 7
RkJQdWJsaXNoZXIy MTk4NDMw